Uncategorized

7 November, 2021

Bonjesta^® Launched Today in Palestine as the Second-Generation Treatment for Morning Sickness

Ramallah, November 7, 2021 – Transmed Pharma is pleased to announce the launch of Bonjesta® (doxylamine suc